The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF.
Ontology highlight
ABSTRACT: Leptin and Brain Derived Neurotrophic Factor (BDNF) pathways are critical players in body weight homeostasis. Noninvasive treatments like environmental stimulation are able to increase response to leptin and induce BDNF expression in the brain. Emerging evidences point to the antidepressant selective serotonin reuptake inhibitor Fluoxetine (FLX) as a drug with effects similar to environmental stimulation. FLX is known to impact on body weight, with mechanisms yet to be elucidated. We herein asked whether FLX affects energy balance, the leptin system and BDNF function. Adult lean male mice chronically treated with FLX showed reduced weight gain, higher energy expenditure, increased sensitivity to acute leptin, increased hypothalamic BDNF expression, associated to changes in white adipose ti
SUBMITTER: Scabia G
PROVIDER: S-EPMC5789051 | biostudies-literature | 2018 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA